dibenzyl trisulfide has been researched along with ER-Negative PR-Negative HER2-Negative Breast Cancer in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aja, J; Araújo, CA; Brantley, E; Delgoda, R; Mavingire, N; Wauchope, S; Wooten, J | 1 |
1 other study(ies) available for dibenzyl trisulfide and ER-Negative PR-Negative HER2-Negative Breast Cancer
| Article | Year |
|---|---|
Dibenzyl trisulfide induces caspase-independent death and lysosomal membrane permeabilization of triple-negative breast cancer cells.
Topics: Benzyl Compounds; Caspases; Cell Line, Tumor; Female; Humans; Lysosomes; Molecular Structure; Sulfides; Triple Negative Breast Neoplasms | 2022 |